2.71
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRVI Giù?
Forum
Previsione
Precedente Chiudi:
$2.62
Aprire:
$2.61
Volume 24 ore:
1.48M
Relative Volume:
0.82
Capitalizzazione di mercato:
$390.17M
Reddito:
$288.95M
Utile/perdita netta:
$-119.03M
Rapporto P/E:
-3.0094
EPS:
-0.9005
Flusso di cassa netto:
$60.67M
1 W Prestazione:
+7.97%
1M Prestazione:
+21.52%
6M Prestazione:
-51.78%
1 anno Prestazione:
-67.27%
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Nome
Maravai Lifesciences Holdings Inc
Settore
Industria
Telefono
(858) 546-0004
Indirizzo
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Confronta MRVI con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MRVI
Maravai Lifesciences Holdings Inc
|
2.71 | 377.22M | 288.95M | -119.03M | 60.67M | -0.9005 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-02-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
2024-12-19 | Iniziato | Guggenheim | Neutral |
2024-12-05 | Downgrade | Goldman | Neutral → Sell |
2024-11-14 | Iniziato | Wolfe Research | Peer Perform |
2024-11-08 | Downgrade | William Blair | Outperform → Mkt Perform |
2024-08-28 | Iniziato | Wells Fargo | Overweight |
2024-08-13 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2024-04-10 | Iniziato | Craig Hallum | Buy |
2023-12-12 | Aggiornamento | BofA Securities | Neutral → Buy |
2023-08-08 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
2023-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
2023-05-09 | Downgrade | Goldman | Buy → Neutral |
2023-01-05 | Downgrade | UBS | Buy → Neutral |
2022-12-14 | Iniziato | Deutsche Bank | Buy |
2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
2022-11-03 | Downgrade | BofA Securities | Buy → Neutral |
2022-08-25 | Iniziato | Credit Suisse | Outperform |
2021-08-05 | Ripresa | Credit Suisse | Outperform |
2020-12-16 | Iniziato | KeyBanc Capital Markets | Overweight |
2020-12-15 | Iniziato | BofA Securities | Buy |
2020-12-15 | Iniziato | Credit Suisse | Outperform |
2020-12-15 | Iniziato | Goldman | Buy |
2020-12-15 | Iniziato | Jefferies | Buy |
2020-12-15 | Iniziato | Robert W. Baird | Outperform |
2020-12-15 | Iniziato | Stifel | Buy |
2020-12-15 | Iniziato | William Blair | Outperform |
2020-12-14 | Iniziato | UBS | Buy |
Mostra tutto
Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie
Is Maravai LifeSciences Holdings Inc. stock overhyped or has real potentialRapid market gains - jammulinksnews.com
What institutions are buying Maravai LifeSciences Holdings Inc. stock nowFree Trend-Following Techniques - jammulinksnews.com
What drives Maravai LifeSciences Holdings Inc. stock priceFree Stock Market Forecast Reports - jammulinksnews.com
Is Maravai LifeSciences Holdings Inc. a good long term investmentFree Daily Trading Room Entry - Autocar Professional
Maravai LifeSciences Holdings Inc. Stock Analysis and ForecastMarket-leading growth rates - jammulinksnews.com
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
What analysts say about Maravai LifeSciences Holdings Inc. stockExceptional trading results - jammulinksnews.com
16,587 Shares in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Purchased by Teacher Retirement System of Texas - Defense World
Maravai LifeSciences appoints Deloitte as new auditor, replaces EY - Investing.com Australia
Maravai LifeSciences appoints Deloitte as new auditor, replaces EY By Investing.com - Investing.com India
Maravai LifeSciences (MRVI) Undergoes Leadership Overhaul Amid Transition - MSN
Johnson Fistel, PLLP Continues Investigation Claims on Behalf of Quantum Computing Inc. (QUBT), AppLovin Corporation (APP), Skyworks Solutions, Inc. (SWKS), and Maravai LifeSciences Holdings, Inc. (MRVI) Long-Term Shareholders - GlobeNewswire
Why Maravai LifeSciences Holdings Inc. stock attracts strong analyst attention5x Profit Potential - beatles.ru
What makes Maravai LifeSciences Holdings Inc. stock price move sharplyHigh Potential Safe Trades - Newser
How Maravai LifeSciences Holdings Inc. stock performs during market volatilityProtected Capital Trading Plan - Newser
MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out - ACCESS Newswire
Here's Why Maravai LifeSciences Holdings (NASDAQ:MRVI) Can Afford Some Debt - 富途牛牛
MARAVAI LIFESCIENCES INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc.MRVI - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Traders Purchase High Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - Defense World
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Rating of “Hold” by Brokerages - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect - ACCESS Newswire
Maravai Lifesciences Holdings Inc Azioni (MRVI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):